[Federal Register Volume 67, Number 161 (Tuesday, August 20, 2002)]
[Notices]
[Page 53950]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-21081]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC): 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Clinical Laboratory Improvement Advisory Committee 
(CLIAC).
    Times and Dates:

8:30 a.m.-5:00 p.m., September 11, 2002.
8:30 a.m.-3:30 p.m., September 12, 2002.
    Place: CDC, Koger Center, Williams Building, Conference Rooms 
1802 and 1805, 2877 Brandywine Road, Atlanta, Georgia 30341.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 100 people.
    Purpose: This committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the 
standards under which clinical laboratories are regulated; the 
impact on medical and laboratory practice of proposed revisions to 
the standards; and the modification of the standards to accommodate 
technological advances.
    Matters To Be Discussed: The agenda will include updates from 
CDC, the Food and Drug Administration, and the Centers for Medicare 
& Medicaid Services; a report on the Coordinating Council for 
Clinical Laboratory Workforce's April 2002 meeting and subsequent 
activities; reports from several organizations on healthcare 
workforce issues; Department of Health and Human Services' 
bioterrorism preparedness and response activities; a report on the 
Secretary's Advisory Committee on Genetic Testing May 2002 meeting; 
genetics testing survey results from the Pacific Northwest Sentinel 
Network; and an update on plans for the April 2003 Quality 
Institute.
    Agenda items are subject to change as priorities dictate.
    Contact Person for Additional Information: Rhonda Whalen, Chief, 
Laboratory Practice Standards Branch, Division of Laboratory 
Systems, Public Health Practice Program Office, CDC, 4770 Buford 
Highway, NE, Mailstop F-11, Atlanta, Georgia 30341-3724, telephone 
770/488-8042, fax 770/488-8279.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: August 14, 2002.
Joseph E. Salter,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 02-21081 Filed 8-19-02; 8:45 am]
BILLING CODE 4163-18-P